Vitamin d Levels and Coronary Catheterization
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00749541|
Recruitment Status : Completed
First Posted : September 9, 2008
Last Update Posted : December 16, 2010
decreased vitamin d levels are associated with increased inflammatory markers,and renin angiotensin levels.
decreased levels were also found to be connected to increased cardiovascular mortality.
we therefore hypothesise that in patients with pathological results of coronary catheterization we will find decreased levels of 25 hydroxy vitamin d.
we will examine patients undergoing elective coronary catheterization and compare two groups: those with normal results and those with pathological results.
|Condition or disease|
|Vitamin D Deficiency|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Observational Model:||Case Control|
|Official Title:||25 Hydroxy Vitamin d Levels in Patients Undergoing an Elective Coronary Catheterization|
|Study Start Date :||November 2008|
|Actual Primary Completion Date :||August 2009|
|Actual Study Completion Date :||August 2009|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00749541
|Assaf Harofeh Mc|
|Principal Investigator:||renana shor, md||assaf harofeh mc|